TRIP6 promotes inflammatory damage via the activation of TRAF6 signaling in a murine model of DSS-induced colitis
Cited by 10
Related Papers
The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target
|Evidence-based Complementary and Alternative Medicine|2021|54
TRIP6 deficiency inhibits inflammatory damage in a murine model of DSS-induced colitis
|Research Square|2021|0